Options for Patients with Polycythemia VeraVideo Categories: Polycythemia Vera
Supported through funding from Incyte
Ruben A. Mesa, MD, Mayo Clinic, Scottsdale Arizona describes why polycythemia vera is a difficult disease for patients to understand and what tools are important to educate. Supported through funding from Incyte
Dr David Spigel discusses challenges and solutions to incorporating cancer biomarkers into patient care, including finding pathology resources to do the testing, issues around reimbursement, and educating colleagues on the value and operational aspects of biomarker testing in delivering personalized therapy to patients with cancer.